ArticleTrials2023

SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection.

Charles O Obonyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.